Literature DB >> 21166712

Barrett's esophagus.

Wayne A Phillips1, Reginald V Lord, Derek J Nancarrow, David I Watson, David C Whiteman.   

Abstract

Barrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal-like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to esophageal adenocarcinoma, the incidence of which has dramatically increased in Western populations in recent years. Although known to arise as a consequence of chronic gastroesophageal reflux, the cellular and molecular mechanisms underlying development Barrett's esophagus and its progression to cancer remain unclear.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21166712     DOI: 10.1111/j.1440-1746.2010.06602.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

Review 1.  Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus.

Authors:  Michael Bennett; Hiroshi Mashimo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 2.  The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.

Authors:  Henry To; Nicholas J Clemons; Cuong P Duong; Alison H Trainer; Wayne A Phillips
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

3.  High rate of missed Barrett's esophagus when screening with forceps biopsies.

Authors:  Mendel E Singer; Robert D Odze
Journal:  Esophagus       Date:  2022-07-22       Impact factor: 3.671

4.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal adenocarcinoma phenotypes.

Authors:  M M Gaye; S J Valentine; Y Hu; N Mirjankar; Z T Hammoud; Y Mechref; B K Lavine; D E Clemmer
Journal:  J Proteome Res       Date:  2012-11-05       Impact factor: 4.466

Review 6.  Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future.

Authors:  Harit Kapoor; Kush Raj Lohani; Tommy H Lee; Devendra K Agrawal; Sumeet K Mittal
Journal:  Clin Transl Sci       Date:  2015-07-27       Impact factor: 4.689

7.  High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.

Authors:  Oliver M Fisher; Angelique J Levert-Mignon; Sarah J Lord; Natalia K Botelho; Araluen K Freeman; Melissa L Thomas; Dan Falkenback; Antony Wettstein; David C Whiteman; Yuri V Bobryshev; Reginald V Lord
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

Review 8.  Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  Nicholas J Clemons; Wayne A Phillips; Reginald V Lord
Journal:  Cancer Biol Ther       Date:  2013-06-17       Impact factor: 4.742

Review 9.  Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers.

Authors:  Young-Min Han; Jong-Min Park; Ho-Jae Lee; Eun-Hee Kim; Ki Baik Hahm
Journal:  J Cancer Prev       Date:  2013-12

10.  Autocrine extra-pancreatic trypsin 3 secretion promotes cell proliferation and survival in esophageal adenocarcinoma.

Authors:  Song Han; Constance W Lee; Jose G Trevino; Steven J Hughes; George A Sarosi
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.